SCHEMBL23960101

SCHEMBL23960101

CC(C)C(=O)OC[C@@H]1CC[C@H](c2ccc3c(/N=C\N(C)C)ncnn23)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26239582 0.86 — —
SCHEMBL23960100 0.84 CYP2A6 (0.33) —
SCHEMBL26027103 0.82 DOT1L (0.36) —
SCHEMBL24606262 0.82 DOT1L (0.36) —
SCHEMBL24606323 0.79 TSHR (0.32) —
SCHEMBL24606316 0.73 DOT1L (0.34) —
SCHEMBL26326827 0.73 — —
SCHEMBL31430674 0.72 POLRMT (0.34) —
SCHEMBL24606256 0.72 DOT1L (0.34) —
SCHEMBL24606310 0.72 DOT1L (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021213288-A1 ANTIVIRAL APPLICATION OF NUCLEOSIDE ANALOG OR COMBINATION FORMULATION CONTAINING NUCLEOSIDE ANALOG 中国科学院上海药物研究所 (CN) 2021-10-28 — — WO disclosed
Send feedback